Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market is a new market research publication announced by Reportstack. The value of the Non-Small Cell Lung Cancer (NSCLC) market is expected to increase significantly over the forecast period across the leading eight developed nations, from $5.1 billion in 2013 to $7.9 billion in 2020. This equates to a Compound Annual Growth Rate (CAGR) of 6.6%. Growth ... Read more
The Non-Small Cell Lung Cancer Market is estimated to be valued at US$ 27252.31 Mn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. It usually develops in the outer parts of the lungs. The three main types of NSCLC are adenocarcinoma, ... Read more
Non-small cell lung cancer (NSCLC) is typically staged using the TNM system, which evaluates the size of the tumor (T), whether cancer has spread to nearby lymph nodes (N), and whether cancer has metastasized or spread to other parts of the body (M). The main stages of NSCLC are:
Stage I. The cancer is contained within the lung and has not spread to lymph nodes or other organs. Stage I is further broken down into ... Read more